HIV drug resistance lasts about one year in women treated with nevirapine to prevent infant infection, study suggests

A new study confirms that a single dose of nevirapine (sdNVP) can lead to HIV treatment failure in women who receive the drug to prevent transmission of the AIDS virus to their infants. However, the increased risk of failure could only be detected in women who began full HIV treatment within about a year after receiving sdNVP.

Read the whole article on Science Daily

More from Science Daily